Denis A, Agouridas C
Dpt., Hoechst Marion Roussel, Romainville Research Center, France.
Bioorg Med Chem Lett. 1998 Sep 22;8(18):2427-32. doi: 10.1016/s0960-894x(98)00402-8.
The synthesis of 6-O-methyl-azithromycin and its aza-ketolide analogue have been achieved by carrying out the Beckmann rearrangement of the readily available 9(E)-6-O-methyl-erythromycin oxime 1. In contrast to the C14 ketolides like HMR 3647, the aza-ketolide turns out to be inactive, thus demonstrating that the addition of a 3 keto function and ring expansion, from 14 to 15 membered ring, could be deleterious for the antibacterial activity.
通过对易于获得的9(E)-6-O-甲基红霉素肟1进行贝克曼重排,实现了6-O-甲基阿奇霉素及其氮杂酮内酯类似物的合成。与C14酮内酯如HMR 3647不同,氮杂酮内酯结果是无活性的,因此表明添加3-酮官能团以及环从14元环扩展到15元环可能对抗菌活性有害。